Bharat Immunologicals Corporate Bonds and Current Financial Leverage

BIBCL -- India Stock  

INR 13.84  0.41  3.05%

Bharat Immunologicals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Bharat Immunologicals financial risk is the risk to Bharat Immunologicals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Check also analysis of Bharat Immunologicals Fundamentals Over Time.

Bharat Immunologicals Financial Leverage Rating

Not Rated
Total Macroaxis Rating
 
N/A
Average S&P Rating

Bharat Immunologicals Debt to Cash Allocation

The company has accumulated 14.53 M in total debt with debt to equity ratio (D/E) of 3.8 implying the company greatly relies on financing operations through barroing. Bharat Immunologicals Biologicals Corp Ltd has Current Ratio of 1.66 which is within standard range for the sector.

Did you try this?

Run Aroon Oscillator Now

   

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Aroon Oscillator

Bharat Immunologicals Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bharat Immunologicals and Tata Consultancy Ser. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also analysis of Bharat Immunologicals Fundamentals Over Time. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.
Search macroaxis.com